What Know About This Fund's Ultragenyx Purchase Move
A hedge fund made a sizable Ultragenyx purchase as the stock slipped about 30% over the prior year. This article brea...
Price weighting biases index behavior differently than market-cap methods. This overview explains the mechanics and the practical impact on portfolio results.
25,572 articlesA hedge fund made a sizable Ultragenyx purchase as the stock slipped about 30% over the prior year. This article brea...
After closing on a rental property, one diligence item can determine whether your cash flow meets expectations. This ...
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
As earnings season hits, the focus is on Taiwan Semiconductor. This original analysis breaks down why prediction: Tai...
ANI Pharma's Q4 2025 results set the stage for the pharma space. This guide breaks down what the numbers mean for the...
A large institutional stake in Enviri sparks questions about the company’s trajectory. This article breaks down what ...
EchoStar joined the S&P 500 on March 23, 2026, carrying unusually high short interest. This article examines the setu...
A booming M&A market lifted Goldman Sachs in Q1, especially in investment banking. This guide breaks down what that m...
Nu Holdings has dropped about 30% from recent peaks. This article breaks down three grounded reasons why the decline ...
The Silver Miners ETF (SLVR) reversed a rapid rise with a sharp one-day decline, underscoring the risk built into lev...
GLD's fee drag and tax treatment can erode bullion gains even as gold prices rise. A closer look at cheaper peers and...
Insider moves can signal a lot about a company’s near-term plans and risk. This deep dive looks at Adaptive Biotechno...